
Subutex (buprenorphine) is a medication that is used alongside counseling and behavioral therapy to treat opioid dependence and opioid use disorder in people who are pregnant.
Both buprenorphine and methadone, another opioid addiction medication, are considered first-line therapy options for people with opioid dependence who are pregnant.
Read more about the benefits of taking Subutex
Is Subutex Safe To Take During Pregnancy?
Subutex, a brand name for buprenorphine, may be prescribed for opioid dependence during pregnancy, as a safer alternative to other opioids such as heroin or oxycodone (OxyContin).
Although the use of Subutex during pregnancy is not risk-free, the benefits of medication for opioid dependency are generally determined to outweigh the risks of stopping treatment.
Why Buprenorphine Is Recommended During Pregnancy
Medication-assisted treatment (MAT) with buprenorphine is one of the most effective treatments for opioid use disorder, a life-threatening disease that affects 1.6 million Americans.
Stopping the use of a medication like buprenorphine during pregnancy carries a risk for relapse to opioid misuse, which could have negative effects on both maternal and fetal health outcomes.
Both the American College of Obstetricians and Gynecologists (ACOG) and Substance Abuse and Mental Health Services Administration (SAMHSA) recognize the benefits of using Subutex to treat opioid use disorder (OUD) while pregnant.
Taking buprenorphine for opioid use disorder while pregnant can:
- prevent complications of opioid abuse
- prevent complications of opioid withdrawal
- prevent relapse to heroin use
- increase safety for the developing fetus
What Are The Risks Of Stopping Subutex While Pregnant?
Subutex is a medication that is administered during opioid detox and prescribed as a maintenance medication for opioid addiction.
Stopping Subutex too quickly or too early could lead to drug relapse, which among other things, could negatively affect pregnancy and fetal development.
Risks of stopping Subutex too quickly during pregnancy include:
- low birth weight
- preterm labor
- fetal distress
- opioid withdrawal
- miscarriage
- fetal death
Before making any changes to your treatment regimen, talk to your doctor about what to do if you become pregnant while taking Subutex.
Risks Of Taking Subutex While Pregnant
Subutex is rated category C by the U.S. Food & Drug Administration for use during pregnancy.
This means that there is evidence that it can affect fetal development, but that the potential benefits of use during pregnancy may warrant its use in people who are opioid-dependent.
Subutex And Neonatal Abstinence Syndrome
Newborns born to mothers who take Subutex during pregnancy may be born with neonatal opioid withdrawal syndrome (NOWS), a form of neonatal abstinence syndrome.
Compared to the use of other opioids, NOWS symptoms developed through maternal use of Subutex for MAT are generally milder and pose less harm to the well-being of newborns.
If properly recognized and treated, NOWS can be effectively managed.
Read more about Subutex and newborn withdrawal
Subutex And Breastfeeding
Subutex is a drug that can pass through breast milk to a newborn. However, buprenorphine is still considered a top choice for opioid use disorder in people who are breastfeeding.
Before, during, and after pregnancy, people with opioid use disorder are advised to talk to their doctor about developing a safe treatment plan, to avoid and prevent health complications.
Alternatives To Taking Subutex While Pregnant
Buprenorphine (Subutex) is commonly prescribed for opioid use disorder during pregnancy. However, a doctor may discuss alternatives if someone has concerns about using Subutex while pregnant.
Taking Methadone Instead Of Subutex During Pregnancy
The primary alternative to buprenorphine for opioid dependence during pregnancy is methadone.
Methadone, a full opioid agonist, has a higher risk for NAS, but is associated with higher treatment retention, compared to buprenorphine during pregnancy.
For decades, methadone has been used to treat opioid dependence and heroin addiction in people who become pregnant, to reduce risks to maternal and fetal health.
Taking Suboxone Instead Of Subutex During Pregnancy
Suboxone is a medication that contains both buprenorphine and naloxone. It is newer than methadone and is also prescribed as a medication for opioid use disorder.
The safety of Suboxone use during pregnancy isn’t formally recognized, due to a lack of evidence to substantiate its safe use.
However, limited research suggests it may be just as safe for use during pregnancy as buprenorphine products like Subutex.
Find Treatment For Opioid Addiction During Pregnancy
Finding an opioid addiction treatment program that specializes in treating pregnant patients can help you receive the care you need during and after pregnancy.
By calling our helpline, we can identify treatment options for opioid addiction near you, and help you find a treatment program that’s right for you or a loved one.
For more information, call us today to find treatment options for opioid addiction near you.
Addiction Resource aims to provide only the most current, accurate information in regards to addiction and addiction treatment, which means we only reference the most credible sources available.
These include peer-reviewed journals, government entities and academic institutions, and leaders in addiction healthcare and advocacy. Learn more about how we safeguard our content by viewing our editorial policy.
- Centers for Disease Control and Prevention (CDC) — Pregnancy and Opioid Pain Medications Fact Sheet
https://www.cdc.gov/drugoverdose/pdf/pregnancy_opioid_pain_factsheet-a.pdf - Centers for Disease Control and Prevention (CDC) — Treatment for Opioid Use Disorder Before, During, and After Pregnancy
https://www.cdc.gov/pregnancy/opioids/treatment.html - Substance Abuse and Mental Health Services Administration (SAMHSA) — Buprenorphine
https://www.samhsa.gov/medication-assisted-treatment/medications-counseling-related-conditions/buprenorphine - U.S. Food & Drug Administration (FDA) — FDA Pregnancy Categories
https://chemm.nlm.nih.gov/pregnancycategories.htm - U.S. Food & Drug Administration (FDA) — Neonatal opioid withdrawal syndrome and medication-assisted treatment with methadone and buprenorphine
https://www.fda.gov/drugs/drug-safety-and-availability/neonatal-opioid-withdrawal-syndrome-and-medication-assisted-treatment-methadone-and-buprenorphine